Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group
 
  • Details

Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group

Journal
Leukemia and Lymphoma
Journal Volume
60
Journal Issue
8
Pages
1942-1949
Date Issued
2019
Author(s)
Chen S.-H.
Chen J.-S.
SHIANN-TANG JOU  
Wu K.-H.
Hung I.-J.
Sheen J.-M.
MENG-YAO LU  
Chen B.-W.
Jaing T.-H.
Wang S.-C.
Lin M.-T.
Chang T.-K.
Liu H.-C.
Yang C.-P.
DOI
10.1080/10428194.2018.1562182
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060179179&doi=10.1080%2f10428194.2018.1562182&partnerID=40&md5=20d2fe8c47971fd5f8bc621cb6b45beb
https://scholars.lib.ntu.edu.tw/handle/123456789/526392
Abstract
Studies of childhood anaplastic large cell lymphoma (ALCL) are less reported from East Asian countries. Clinical features and outcome of 90 children with ALCL in Taiwan were analyzed. The median age at diagnosis was 11.7 years. The most common presentation was lymph node involvement (86.7%). Advanced diseases accounted for 70% of patients at diagnosis. Most patients (93.1%) had positive staining for anaplastic lymphoma kinase. The five-year overall survival and event-free survival (EFS) rates were 79.7% and 73.3%, respectively. Bone marrow involvement, advanced stage, and thoracopulmonary ALCL were adverse prognostic factors for EFS (p=.05,.04, and.03, respectively). In multivariate analysis, only thoracopulmonary ALCL had a marginal significance on worse EFS (p=?.054). We suggested that children with thoracopulmonary ALCL may need to intensify the treatment, and introduction of new targeted therapies for relapsed/refractory disease will be required. ? 2019, ? 2019 Informa UK Limited, trading as Taylor & Francis Group.
SDGs

[SDGs]SDG3

Other Subjects
anaplastic lymphoma kinase; antineoplastic agent; adult; allogeneic hematopoietic stem cell transplantation; anaplastic large cell lymphoma; Article; autologous hematopoietic stem cell transplantation; cancer diagnosis; cancer prognosis; cancer staging; child; childhood cancer; clinical feature; clinical outcome; cohort analysis; computer assisted tomography; drug megadose; event free survival; female; follow up; human; major clinical study; male; nuclear magnetic resonance imaging; overall survival; priority journal; Taiwan; treatment outcome; adolescent; age; anaplastic large cell lymphoma; health survey; mortality; outcome assessment; preschool child; prognosis; survival analysis; Adolescent; Age Factors; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Neoplasm Staging; Patient Outcome Assessment; Population Surveillance; Prognosis; Survival Analysis; Taiwan
Publisher
Taylor and Francis Ltd
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science